Cargando…
The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092917/ https://www.ncbi.nlm.nih.gov/pubmed/33649117 http://dx.doi.org/10.1128/AAC.00020-21 |
| _version_ | 1783687711067996160 |
|---|---|
| author | Tomita, Yuriko Takeda, Makoto Matsuyama, Shutoku |
| author_facet | Tomita, Yuriko Takeda, Makoto Matsuyama, Shutoku |
| author_sort | Tomita, Yuriko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8092917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80929172021-05-18 The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells Tomita, Yuriko Takeda, Makoto Matsuyama, Shutoku Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2021-04-19 /pmc/articles/PMC8092917/ /pubmed/33649117 http://dx.doi.org/10.1128/AAC.00020-21 Text en Copyright © 2021 Tomita et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Tomita, Yuriko Takeda, Makoto Matsuyama, Shutoku The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title | The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title_full | The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title_fullStr | The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title_full_unstemmed | The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title_short | The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells |
| title_sort | anti-influenza virus drug favipiravir has little effect on replication of sars-cov-2 in cultured cells |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092917/ https://www.ncbi.nlm.nih.gov/pubmed/33649117 http://dx.doi.org/10.1128/AAC.00020-21 |
| work_keys_str_mv | AT tomitayuriko theantiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells AT takedamakoto theantiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells AT matsuyamashutoku theantiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells AT tomitayuriko antiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells AT takedamakoto antiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells AT matsuyamashutoku antiinfluenzavirusdrugfavipiravirhaslittleeffectonreplicationofsarscov2inculturedcells |